Advertisement

Digestive Diseases and Sciences

, Volume 63, Issue 10, pp 2813–2814 | Cite as

Correction to: Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration

  • Yuval A. Patel
  • Elizabeth J. Gifford
  • Lisa M. Glass
  • Marsha J. Turner
  • Byungjoo Han
  • Cynthia A. Moylan
  • Steve Choi
  • Ayako Suzuki
  • Dawn Provenzale
  • Christine M. Hunt
Correction
  • 165 Downloads

Correction to: Digestive Diseases and Sciences  https://doi.org/10.1007/s10620-018-5123-3

The original version of the article unfortunately contained errors in Table 3, Risk Factor column headings “Age > 50 (n = 115),” “Age > 50–64 (n = 154),” and “Age > 65 + (n = 60).” Corrected version of Table 3 is given below.
Table 3

Fibrosis prediction scores by age (using alternative thresholds for age ≥ 65)

Risk factor

AUROC 95% CI

ROC lower bound

ROC upper bound

Cutoff

Sensitivity

Specificity

PPV

NPV

LR +

LR −

Odds ratio

Prevalence

Age < 50 (n  = 115)

NAFLD fibrosis > 0.676

0.72

0.56

0.87

0.676

45.45

97.94

71.43

94.06

22.05

0.56

39.58

10.19

NAFLD fibrosis < − 1.455

0.22

0.12

0.32

− 1.455

9.09

35.05

1.56

77.27

0.14

2.59

0.5

10.19

FIB-4 > 2.67

0.62

0.49

0.74

2.67

25

98.04

60

91.74

12.75

0.76

16.67

10.53

FIB-4 < 1.3

0.25

0.10

0.39

1.3

33.33

15.69

4.44

66.67

0.40

4.25

0.09

10.53

BARD 2–4

0.74

0.62

0.86

2

83.33

65.05

21.74

97.10

2.38

0.26

9.31

10.43

BARD 0–1

0.26

0.14

0.38

1

16.67

34.95

2.90

78.26

0.26

2.38

0.11

10.43

Age 5064 (n = 154)

NAFLD fibrosis > 0.676

0.76

0.68

0.83

0.676

68

83.51

68

83.51

4.12

0.38

10.76

34.01

NAFLD fibrosis < − 1.455

0.32

0.27

0.37

− 1.455

2

61.9

2.63

55.05

1.58

0.04

0.03

34.01

FIB4 > 2.67

0.76

0.69

0.83

2.67

54.90

98

93.33

80.99

27.45

0.46

59.65

33.77

FIB-4 < 1.3

0.25

0.19

0.32

1.3

7.84

43

6.56

47.78

0.14

2.14

0.06

33.77

BARD 2–4

0.67

0.62

0.73

2

96.08

38.61

44.14

95.12

1.57

0.10

15.41

33.55

BARD 0–1

0.33

0.27

0.38

1

3.92

61.39

4.89

55.86

0.10

1.57

0.06

33.55

Age ≥ 65 (n = 60)

NAFLD fibrosis > 0.676

0.71

0.59

0.83

0.676

74.07

67.74

66.67

75

2.30

0.38

6

46.55

NAFLD fibrosis < –0.12

0.33

0.22

0.44

− 0.12

14.81

51.61

21.05

41.03

0.31

1.65

0.19

46.55

NAFLD fibrosis < –1.455

0.43

0.36

0.51

− 1.455

3.70

83.87

16.67

50

0.23

1.15

0.2

46.55

FIB4 > 3.25

0.80

0.70

0.89

3.25

65.52

93.55

90.48

74.36

10.16

0.37

27.55

48.33

FIB4 > 2.67

0.80

0.70

0.90

2.67

75.86

83.87

81.48

78.79

4.70

0.29

16.34

48.33

FIB4 < 2.0 if age ≥ 65

0.33

0.22

0.44

2

13.79

51.61

21.05

39.02

0.29

1.67

0.17

48.33

FIB-4 < 1.3

0.49

0.42

0.56

1.3

6.90

90.32

40

50.91

0.71

1.03

0.69

48.33

BARD 2–4

0.63

0.54

0.72

2

96.55

29.03

56

90

1.36

0.12

11.45

48.33

BARD 0–1

0.37

0.28

0.46

1

3.45

70.97

10

44

0.12

1.36

0.09

48.33

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Yuval A. Patel
    • 1
  • Elizabeth J. Gifford
    • 2
  • Lisa M. Glass
    • 3
    • 4
  • Marsha J. Turner
    • 5
  • Byungjoo Han
    • 5
  • Cynthia A. Moylan
    • 1
  • Steve Choi
    • 1
  • Ayako Suzuki
    • 1
  • Dawn Provenzale
    • 1
    • 5
  • Christine M. Hunt
    • 1
    • 5
  1. 1.Department of MedicineDuke University Medical Center, Durham Veterans Administration Medical CenterDurhamUSA
  2. 2.Sanford School of Public PolicyDuke UniversityDurhamUSA
  3. 3.Department of MedicineUniversity of MichiganAnn ArborUSA
  4. 4.VA Ann Arbor Healthcare SystemsAnn ArborUSA
  5. 5.Cooperative Studies Program Epidemiology CenterDurham Veterans Administration Medical CenterDurhamUSA

Personalised recommendations